Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats

碩士 === 中國醫藥大學 === 醫學研究所碩士班 === 94 === The aim of this study was to investigate the neuroprotective effect of selective estrogen receptor (ER) agonists on the nigro-striatal system. Parkinsonism was induced in ovariectomized rats by treatment of rotenone via subcutaneous osmotic minipump (3 mg/kg/day...

Full description

Bibliographic Details
Main Authors: Yu-Jei Lei, 雷玉潔
Other Authors: 陳卓昇
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/77354310720068516396
id ndltd-TW-094CMCH5534025
record_format oai_dc
spelling ndltd-TW-094CMCH55340252016-05-27T04:18:56Z http://ndltd.ncl.edu.tw/handle/77354310720068516396 Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats 不同動情素接受體致效劑對魚藤酮誘發之巴金森氏症的影響 Yu-Jei Lei 雷玉潔 碩士 中國醫藥大學 醫學研究所碩士班 94 The aim of this study was to investigate the neuroprotective effect of selective estrogen receptor (ER) agonists on the nigro-striatal system. Parkinsonism was induced in ovariectomized rats by treatment of rotenone via subcutaneous osmotic minipump (3 mg/kg/day) for 2 weeks. These rats simultaneously received daily injection of estradiol (10 ug/kg) or selective estrogen receptor (ER) agonists (1 mg/kg). Locomotor activities were observed before and 2 weeks after rotenone treatment. The results revealed that ER alpha agonist improved the locomotor activities in rotenone-treated rats. Tyrosine hydroxylase (TH) levels in substantia nigra were not different among treatment groups. Levels of Mn-SOD and Bcl2 also were not altered. Cu/Zn-SOD was decreased by rotenone treatment.However, ER agonist failed to prevent the reduction. These data suggest that ER alpha may be involved in the neuroprotective effects of estrogen on nigro-striatal system. 陳卓昇 2006 學位論文 ; thesis 72 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 中國醫藥大學 === 醫學研究所碩士班 === 94 === The aim of this study was to investigate the neuroprotective effect of selective estrogen receptor (ER) agonists on the nigro-striatal system. Parkinsonism was induced in ovariectomized rats by treatment of rotenone via subcutaneous osmotic minipump (3 mg/kg/day) for 2 weeks. These rats simultaneously received daily injection of estradiol (10 ug/kg) or selective estrogen receptor (ER) agonists (1 mg/kg). Locomotor activities were observed before and 2 weeks after rotenone treatment. The results revealed that ER alpha agonist improved the locomotor activities in rotenone-treated rats. Tyrosine hydroxylase (TH) levels in substantia nigra were not different among treatment groups. Levels of Mn-SOD and Bcl2 also were not altered. Cu/Zn-SOD was decreased by rotenone treatment.However, ER agonist failed to prevent the reduction. These data suggest that ER alpha may be involved in the neuroprotective effects of estrogen on nigro-striatal system.
author2 陳卓昇
author_facet 陳卓昇
Yu-Jei Lei
雷玉潔
author Yu-Jei Lei
雷玉潔
spellingShingle Yu-Jei Lei
雷玉潔
Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
author_sort Yu-Jei Lei
title Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
title_short Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
title_full Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
title_fullStr Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
title_full_unstemmed Effects of Different Estrogen Receptor Agonists on Rotenone-induced Parkinsonism in Rats
title_sort effects of different estrogen receptor agonists on rotenone-induced parkinsonism in rats
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/77354310720068516396
work_keys_str_mv AT yujeilei effectsofdifferentestrogenreceptoragonistsonrotenoneinducedparkinsonisminrats
AT léiyùjié effectsofdifferentestrogenreceptoragonistsonrotenoneinducedparkinsonisminrats
AT yujeilei bùtóngdòngqíngsùjiēshòutǐzhìxiàojìduìyúténgtóngyòufāzhībājīnsēnshìzhèngdeyǐngxiǎng
AT léiyùjié bùtóngdòngqíngsùjiēshòutǐzhìxiàojìduìyúténgtóngyòufāzhībājīnsēnshìzhèngdeyǐngxiǎng
_version_ 1718283227864498176